Summary & Overview
HCPCS Level II J0456: Azithromycin 500 mg Injection
HCPCS Level II code J0456 denotes a 500 mg injectable dose of azithromycin, a macrolide antibiotic commonly used in outpatient and ambulatory settings. This code is important for claims processing and clinical documentation when azithromycin is administered by injection rather than orally. Nationally, injectable antibiotic billing affects practice workflows, inventory management, and payer reimbursement practices across commercial and public programs.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what J0456 represents clinically, where the service is typically provided, and which payers commonly adjudicate these claims. The publication summarizes typical billing considerations, common modifiers that may accompany injectable drug administration (listed separately), and how J0456 fits into outpatient antimicrobial therapy workflows.
This report provides benchmarks for billing frequency and reimbursement patterns where available, highlights relevant policy updates affecting injectable drug coding and coverage, and offers clinical context about use cases for azithromycin injections. Data not available in the input is noted as such in appropriate sections.
Billing Code Overview
HCPCS Level II code J0456 represents an injection of azithromycin, 500 mg. This code describes a single-dose injectable formulation of the macrolide antibiotic azithromycin used for the treatment of susceptible bacterial infections.
Service Type: Injectable antibiotic administration
Typical Site of Service: Outpatient clinic, physician office, or ambulatory infusion center
Clinical & Coding Specifications
Clinical Context
A typical patient is a 28-year-old adult presenting to an urgent care clinic or outpatient infusion center with acute uncomplicated bacterial infection requiring parenteral macrolide therapy, such as community-acquired pneumonia in a patient unable to tolerate oral medications, or a sexually transmitted infection when intramuscular therapy is indicated. The clinical workflow begins with triage and assessment by a licensed clinician (physician, nurse practitioner, or physician assistant). Indications for J0456 (injection, azithromycin, 500 mg) are confirmed, allergies and weight are assessed, and informed consent for intramuscular or intravenous administration is obtained. The pharmacy or medication room prepares the 500 mg azithromycin dose per facility protocol. A registered nurse or clinician performs the injection (typically intramuscular) or IV administration, documents lot number and expiration, monitors the patient for immediate adverse reactions for the recommended observation period, and records the administration in the medical record. Billing uses J0456 for the drug supply; appropriate evaluation and management or procedural CPT codes are billed separately as clinically indicated. Typical sites of service include urgent care centers, outpatient clinics, emergency departments, and infusion centers.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|